InfuSystem Holdings, Inc.

US$13.69As of Sun 8 Nov 2026, 12:00 UTC
AMEX:INFUHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 18.26%
Div yield —
ROE 15.78%
Medical Devices
Beta (5Y) 1.38
PE TTM 31.10
TSR TTM 32.14%
Mkt cap US$274.2M
ROIC 11.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
23.96%
(69.09%)
Hold 5|1|7|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.19
0.20
0.20
4.17%
4.62%
2.81%
5.26%
Revenue$M
20.32
20.15
21.08
20.72
5.90%
(0.08%)
1.50%
2.80%
Peers (US$274.2M)
Cap (US$)
PE
262.1M
—
276.0M
7.401x
Capital
TTM
5Y
10Y
Leveragex
14.69
(1.290)
(1.053)
EBIT/Intx
3.781
0.817
0.780
Own earn%
188.32
(169.39)
(161.34)
Sh yield%
36.97
15.48
15.76
Owners
Insiders/Inst%
3.49
48.09
Short interest%
3.41
SBC / revenue%
5.95
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
26–30
$1 testx
—
Incr. ROIC%
4